Dayarathna Shashika, Kuruppu Heshan, Silva Tehani, Gomes Laksiri, Shyamali N L Ajantha, Jeewandara Chandima, Ariyaratne Dinuka, Ramu Shyrar Tanussiya, Wijewickrama Ananda, Ogg Graham S, Malavige Gathsaurie Neelika
University of Sri Jayewardenepura.
National Institute of Infectious Diseases.
Res Sq. 2024 Aug 26:rs.3.rs-4771323. doi: 10.21203/rs.3.rs-4771323/v1.
As many studies have shown conflicting results regarding the extent of viraemia and clinical disease severity, we sought to investigate if viraemia during early dengue illness is associated with subsequent clinical disease severity.
Realtime PCR was carried out to identify the dengue virus (DENV serotype), in 362 patients, presenting within the first 4 days of illness, from 2017 to 2022, in Colombo Sri Lanka. To characterize subsequent clinical disease severity, all patients were followed throughout their illness daily and disease severity classified according to WHO 1997 and 2009 disease classification.
263 patients had DF, 99 progressed to develop DHF, and 15/99 with DHF developed shock (DSS). Although the viral loads were higher in the febrile phase in patients who progressed to develop DHF than in patients with DF this was not significant (p=0.5). Significant differences were observed in viral loads in patients infected with different DENV serotypes (p=0.0009), with lowest viral loads detected in DENV2 and the highest viral loads in DENV3. Sub-analysis for association of viraemia with disease severity for each DENV serotyped was again not significant. Although those infected with DENV2 had lower viral loads, infection with DENV2 was significantly associated with a higher risk of developing DHF (p=0.011, Odds ratio 1.9; 95% CI 1.164 to 3.078). Based on the WHO 2009 disease classification, 233 had dengue with warning signs (DWW), 114 dengue without warning signs (DWoWS), and 15 had severe dengue (SD). No significant difference was observed in the viral loads between those with SD, DWW and DWoWS (p=0.27).
Viral loads were significantly different in the febrile phase between different DENV serotypes, and do not appear to significantly associate with subsequent clinical disease severity in a large Sri Lankan cohort.
由于许多研究在病毒血症程度和临床疾病严重程度方面显示出相互矛盾的结果,我们试图调查登革热早期疾病期间的病毒血症是否与随后的临床疾病严重程度相关。
对2017年至2022年在斯里兰卡科伦坡发病后4天内就诊的362例患者进行实时PCR,以鉴定登革热病毒(登革热血清型)。为了描述随后的临床疾病严重程度,在患者整个病程中每天对所有患者进行随访,并根据世界卫生组织1997年和2009年的疾病分类对疾病严重程度进行分类。
263例患者患有登革热(DF),99例进展为登革出血热(DHF),其中15例/99例DHF患者发展为休克(登革休克综合征,DSS)。虽然进展为DHF的患者在发热期的病毒载量高于DF患者,但差异不显著(p = 0.5)。在感染不同登革热病毒血清型的患者中观察到病毒载量存在显著差异(p = 0.0009),登革热病毒2型(DENV2)检测到的病毒载量最低,登革热病毒3型(DENV3)的病毒载量最高。对每种登革热病毒血清型的病毒血症与疾病严重程度的关联进行亚分析,结果再次不显著。虽然感染DENV2的患者病毒载量较低,但感染DENV2与发生DHF的风险显著相关(p = 0.011,比值比1.9;95%可信区间1.164至3.078)。根据世界卫生组织2009年的疾病分类,233例患者有登革热预警征象(DWW),114例患者无登革热预警征象(DWoWS),15例患者患有重症登革热(SD)。SD、DWW和DWoWS患者之间的病毒载量无显著差异(p = 0.27)。
在一个大型斯里兰卡队列中,不同登革热病毒血清型在发热期的病毒载量存在显著差异,但似乎与随后的临床疾病严重程度无显著关联。